Loading...

NewGenIvf Group Limited

NIVFW•NASDAQ
Healthcare
Medical - Care Facilities
$0.03
$0.002(9.36%)

NewGenIvf Group Limited (NIVFW) Stock Overview

Explore NewGenIvf Group Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 62.6/100

Key Financials

Market Cap5.6M
P/E Ratio0.00
EPS (TTM)N/A
ROE-0.39%
Fundamental Analysis

AI Price Forecasts

1 Week$0.03
1 Month$0.03
3 Months$0.05
1 Year TargetN/A

NIVFW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of NewGenIvf Group Limited (NIVFW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 56.93, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.00 and a market capitalization of 5.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Technical Indicators

56.93RSI (14)
0.00MACD
68.44ADX
Stats data is not available for NIVFWStats details for NIVFW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for NIVFWAnalyst Recommendations details for NIVFW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company's fertility treatment solutions include in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also provides IVF treatment; surrogacy and ancillary caring services, including regular body check, as well as vitamins, supplements, and medicines to surrogate mothers; and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. The company offers its services through its clinics. NewGenIvf Group Limited was founded in 2010 and is based in Bangkok, Thailand.

CEO

Wing Fung Siu

Employees

76

Headquarters

PS Tower, Bangkok

Founded

1970

Frequently Asked Questions

;